Reports

Department of Health & Human Services OIG

End-Stage Renal Disease Network Organizations' Reported Actions Taken in Response to the COVID-19 Pandemic

Full Details: Oversight.gov Report Page

Department of Health & Human Services OIG

FDA’s Work with the Tri-Agency Task Force for Emergency Diagnostics Helped Labs Implement COVID-19 Tests

Full Details: Oversight.gov Report Page

Department of Health & Human Services OIG

FDA Repeatedly Adapted Emergency Use Authorization Policies to Address the Need for COVID-19 Testing

Full Details: Oversight.gov Report Page

Department of Labor OIG

Alert Memorandum: Potentially Fraudulent Unemployment Insurance Payments in High-Risk Areas Increased to $45.6 Billion

Full Details: Oversight.gov Report Page

Other | 9/21/2022

Department of Health & Human Services OIG

IHS's National Supply Service Center Was Generally Effective in Providing Supplies to Facilities During the COVID-19 Pandemic, but Its Internal Controls Could Be Improved

Full Details: Oversight.gov Report Page

Department of Health & Human Services OIG

Certain Life Care Nursing Homes May Not Have Complied With Federal Requirements for Infection Prevention and Control and Emergency Preparedness

Full Details: Oversight.gov Report Page

Department of Health & Human Services OIG

The IHS Telehealth System Was Deployed Without Some Required Cybersecurity Controls

Full Details: Oversight.gov Report Page

Department of Health & Human Services OIG

Medicare Telehealth Services During the First Year of the Pandemic: Program Integrity Risks

Full Details: Oversight.gov Report Page

Department of Health & Human Services OIG

Certain Medicare Beneficiaries, Such as Urban and Hispanic Beneficiaries, Were More Likely Than Others to Use Telehealth During the First Year of the COVID-19 Pandemic

Full Details: Oversight.gov Report Page

Department of Health & Human Services OIG

HHS Did Not Fully Comply With Federal Requirements and HHS Policies and Procedures When Awarding and Monitoring Contracts for Ventilators

Full Details: Oversight.gov Report Page

Date Range

Report Type

Report Category

Submitting Agency

State/Local Agency

State (State and Local Reports)

Fraud Type

Agency Reviewed

Related Organizations

Management Challenges

Any Recommendations

Any Open Recommendations

Reports

End-Stage Renal Disease Network Organizations' Reported Actions Taken in Response to the COVID-19 Pandemic

FDA’s Work with the Tri-Agency Task Force for Emergency Diagnostics Helped Labs Implement COVID-19 Tests

FDA Repeatedly Adapted Emergency Use Authorization Policies to Address the Need for COVID-19 Testing

Alert Memorandum: Potentially Fraudulent Unemployment Insurance Payments in High-Risk Areas Increased to $45.6 Billion

IHS's National Supply Service Center Was Generally Effective in Providing Supplies to Facilities During the COVID-19 Pandemic, but Its Internal Controls Could Be Improved

Certain Life Care Nursing Homes May Not Have Complied With Federal Requirements for Infection Prevention and Control and Emergency Preparedness

The IHS Telehealth System Was Deployed Without Some Required Cybersecurity Controls

Medicare Telehealth Services During the First Year of the Pandemic: Program Integrity Risks

Certain Medicare Beneficiaries, Such as Urban and Hispanic Beneficiaries, Were More Likely Than Others to Use Telehealth During the First Year of the COVID-19 Pandemic

HHS Did Not Fully Comply With Federal Requirements and HHS Policies and Procedures When Awarding and Monitoring Contracts for Ventilators

Glossary

Glossary name will go here